Optimal levetiracetam dosage regimen for preventing seizures related to immune effector cell-associated neurotoxicity syndrome.

Kikushige, Yoshikane; Uchida, Mayako; Hirota, Takeshi; Sugimoto, Yuri; Tsuchiya, Yuichi; Wada, Yudai; Yamamoto, Nanae; Uematsu, Hoyumi; Kobayashi, Daisuke; Yamauchi, Takuji; Jinnouchi, Fumiaki; Sakoda, Teppei; Miyawaki, Kohta; Shima, Takahiro; Takigawa, Ken; Shimo, Masatoshi; Mori, Yasuo; Nakao, Satoshi; Nakamura, Takahiro; Mine, Masatoshi; Akashi, Koichi; Kato, Koji

doi:10.1038/s41409-026-03038-1

Optimal levetiracetam dosage regimen for preventing seizures related to immune effector cell-associated neurotoxicity syndrome.

2026-11-14, Bone Marrow Transplantation (10.1038/s41409-026-03038-1) (online)
Yoshikane Kikushige, Mayako Uchida, Takeshi Hirota, Yuri Sugimoto, Yuichi Tsuchiya, Yudai Wada, Nanae Yamamoto, Hoyumi Uematsu, Daisuke Kobayashi, Takuji Yamauchi, Fumiaki Jinnouchi, Teppei Sakoda, Kohta Miyawaki, Takahiro Shima, Ken Takigawa, Masatoshi Shimo, Yasuo Mori, Satoshi Nakao, Takahiro Nakamura, Masatoshi Mine, Koichi Akashi, and Koji Kato (?)

This article has not yet been included in any curations.

Comments

There are no comments on this article yet.

You need to login or register to comment.

BioSothis

Optimal levetiracetam dosage regimen for preventing seizures related to immune effector cell-associated neurotoxicity syndrome.